tm logo

Monitor this mark

View On USPTO

ABRILADA
Live/Registered
REGISTERED

on 16 Jan 2024

Last Applicant/ Owned by

Pfizer Inc.

66 Hudson Boulevard East

New York

NY

10001-219

Serial Number

90229278 filed on 01st Oct 2020

Registration Number

7279703 registered on 16th Jan 2024

in the Principal Register

Correspondent Address

Richard A. Friedman

Richard A. Friedman PFIZER INC.

NEW YORK, NY 10017

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ABRILADA

Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis

First Use Date in General

18th Oct 2023

First Use Date in Commerce

18th Oct 2023

Mark Details

Serial Number

No 90229278

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
16th Jan 2024REGISTERED-PRINCIPAL REGISTER
16th Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
12th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11th Dec 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th Dec 2023STATEMENT OF USE PROCESSING COMPLETE
05th Dec 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Nov 2023ASSIGNED TO EXAMINER
21st Nov 2023TEAS STATEMENT OF USE RECEIVED